Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Global Malaria Vaccines Market, By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine), Agent (Plasmodium Falciparum, Plasmodium Vivax), Distribution Channel (Hospitals, Clinics, Community Centers), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Apr 2017

Malaria Vaccines – Paving the Way for a Malaria-free World Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led t

Coherent Market Insights
Global Anti-Suicide Drugs Market, By Chemistry Type (Anti-Depressants and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, Antibiotic Analog), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : Mar 2017

Anti-Suicide Drugs – Beacon Light of Life on the Horizon Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Ant

Coherent Market Insights
Unfractionated Heparin Market, By Source (Bovine and Porcine), By Application (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Embolism, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Academic and Research Organizations), and By Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Unfractionated heparin (UFH) is a natural agent widely used to prevent clot formation in vessels. Unfractionated heparin is a fast-acting blood thinner, which works with antithrombin, a natural protein in the body, to block clot formation. UFH is administered to patie

Coherent Market Insights
Kaposi Sarcoma Treatment Market, By Treatment Type (Chemotherapy, Immunotherapy, HAART, and Drugs (Vinblastine, Bleomycin, Etoposide, Doxorubicin, Paclitaxel, and Others)), By End User (Hospitals, Oncology Clinics, Ambulatory Surgical Centers Pharmaceutical Companies, and Academic and Research Organizations), and By Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Kaposi sarcoma is a malignant tumor disease majorly associated with skin, mucous membranes, lymph nodes, and other organs. Kaposi sarcoma causes lesions to grow in the skin, in the mucous membranes lining the mouth, nose, and throat, lymph nodes, and other organs. Hum

Coherent Market Insights
Cystinosis Treatment Market, by Treatment (Cysteine Depleting Therapy, Symptomatic Therapy, and Renal transplantation), by End User (Hospitals, Specialty Clinics, and Others) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Cystinosis is a condition characterized by accumulation of the cystine (amino acid) within cells. High amount of cystine damages cells and often forms crystals that can damage tissues and organs. The eyes and kidneys are mainly susceptible to damage; however, the panc

Coherent Market Insights
Sugar-based Excipients Market, by Product Type (Actual Sugars, Sugar Alcohols, and Artificial Sweeteners), by Excipient Type (Powders/granules, Direct Compression Sugars, Crystals, and Syrups), by Route of Administration (Oral, Parenteral, Topical, and Other Route of Administration), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

An excipient is an inactive substance formulated with the active ingredient of a medication for the purpose of bulking-up Route of Administration that contain potent active ingredients. These substances improve bulkiness and dissolution rate of the drug and are crucia

Coherent Market Insights
Mitochondrial Disorders Treatment Market, by Therapy Type (Dietary Therapy, Vitamin and Supplement Therapy, and Pipeline Therapies), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Mitochondrial disorders are inherited chronic disorders characterized by a wide range of biochemical and genetic mitochondrial defects and mutations. The disorder affects multiple organs, which includes brain, heart, liver, skeletal muscles, kidney, and respiratory sy

Coherent Market Insights
Phenylketonuria Treatment Market, by Treatment Type (Drug (Kuvan, Pegvaliase and Others) and Dietary Supplement), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Phenylketonuria (PKU) is a rare genetic disorder caused due to increased level of phenylalanine in the blood. The excess amount of phenylalanine can cause intellectual disability and other serious health problems. The most severe condition of this disorder is termed a

Coherent Market Insights
Animal Nutrition Market, by Species (Poultry, Ruminant, Aquaculture, Swine, and Others), by Product Type (Pet Food, Amino Acids, Carotenoids, Enzymes, Eubiotics, Minerals, Lipids, and Vitamins) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Animal nutrition focuses on dietary needs of animals, chiefly those in food production and agriculture, however also in aquariums, zoos, and wildlife management. Animal nutrition is important for the productivity and health of agricultural animals. Various organizatio

Coherent Market Insights
Specialty CRO's Market, by Therapeutic Area (Oncology, Cardiovascular Disease, Diabetes, and Others), by Service (Clinical Trial Management Service, Clinical Data Management Service, Pharmacovigilance Service, Regulatory Affairs/Medical Writing Service, and Others), and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Specialty clinical research organizations are distinct service providers in clinical research domain with expertise based on different criteria. Earlier pharmaceutical and biotech firms, which are research driven had conducted majority of the clinical research. Howeve

Coherent Market Insights
Autism Disorder Treatment Market, by Drug Type (Anticonvulsants, Antipsychotics, Insomnia Drugs, Selective Serotonin Reuptake Inhibitors (SSRIs), and Others), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Autism, scientifically referred as autism spectrum disorder (ASD) is a range of complex neurological disorders that is characterized by symptoms including challenges with social skills, repetitive behaviors, as well as issues with speech and non-verbal communication.

Coherent Market Insights
Acute Lymphoblastic Leukemia Therapeutics Market, by Drug Type, (Chemotherapy Drugs, Immunotherapy Drugs, Targeted Therapy Drugs, and Others), by Indication (Precursor B Cell ALL, Mature B Cell ALL, and Precursor T Cell ALL), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Acute lymphoblastic leukemia (ALL) is a type of cancer affecting the bone marrow and blood. The condition is characterized by overproduction of immature white blood cells, also known as lymphoblast. The immature or abnormal cells are unable to function properly and bu

Coherent Market Insights
Eisenmenger Syndrome Treatment Market, by Drug Type (Antiarrhythmic Agents, Blood Thinning Agents, Endothelin Receptor Antagonist, and Others), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Eisenmenger Syndrome develops due to high blood pressure in the lungs, which is known as pulmonary hypertension. Pulmonary hypertension occurs due to certain congenital heart defects that cause the blood to flow from left side of the heart to right side abnormally (le

Coherent Market Insights
Hepatocellular Carcinoma Drugs Market, by Drug Class, (PD-1/PD-L1 Inhibitors, and Tyrosine Kinase Inhibitors), by End User (Hospitals, Clinics, and Cancer Rehabilitation Centers, and Ambulatory Surgical Centers) and Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Hepatocellular carcinoma (HCC) is a major type of primary liver cancer that arises from the liver cells or hepatocytes. The disease is found to occur mainly in patients with hepatitis B, hepatitis C, cirrhosis, obesity, and diabetes. Diagnosis of hepatocellular carcin

Coherent Market Insights
Amebiasis Treatment Market, by Drug Type (Metronidazole, Paromomycin, Tinidazole, Iodoquinol, Dehydroemetine, Chloroquine Phosphate, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Aug 2018

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain. Amebiasis is common in regions with low developed sanitation facilities such as Asia Pacific, Cen

Coherent Market Insights
Liver Cancer Therapeutics Market, by Drug Class (Targeted Therapy (Sorafenib (Nexavar), Regorafenib (Stivarga)), Immunotherapy (Nivolumab (Opdivo)), and Chemotherapy), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Aug 2018

Liver cancer is a type of malignant hepatic tumor in or on the liver, which may cause due to excessive alcohol intake, diabetes, certain inherited liver diseases, and hepatitis. Symptoms of this cancer appears only when it is in the advanced stage. The most common typ

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.